# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Oppenheimer analyst Jay Olson maintains Prothena Corp (NASDAQ:PRTA) with a Outperform and lowers the price target from $66 t...
Cantor Fitzgerald analyst Charles Duncan reiterates Prothena Corp (NASDAQ:PRTA) with a Overweight.
RBC Capital analyst Brian Abrahams maintains Prothena Corp (NASDAQ:PRTA) with a Sector Perform and lowers the price target f...
RBC Capital analyst Brian Abrahams reiterates Prothena Corp (NASDAQ:PRTA) with a Sector Perform and maintains $28 price target.
JMP Securities analyst Jason Butler maintains Prothena Corp (NASDAQ:PRTA) with a Market Outperform and lowers the price targ...
HC Wainwright & Co. analyst Andrew Fein maintains Prothena Corp (NASDAQ:PRTA) with a Buy and lowers the price target fro...
Prothena Corp (NASDAQ:PRTA) reported quarterly losses of $(1.34) per share which missed the analyst consensus estimate of $(1.2...